Business Description
IHH Healthcare Bhd
SIC : 8062
ISIN : MYL5225OO007
Total Employee Number:
70,000Compare
Compare
Traded in other countries / regions
5225.MalaysiaQ0F.SingaporeIHHHF.USA IPO Date
2012-07-25Description
IHH Healthcare Bhd is one of the world's largest private healthcare groups, operating a network of hospitals and healthcare facilities across Asia and Europe. Its principal brands include Acibadem in Turkey and Europe, Gleneagles, Mount Elizabeth, Pantai, and Parkway in Singapore and Malaysia, and Fortis and Gleneagles in India. The group provides primary, secondary, tertiary, and quaternary care, along with ancillary services such as diagnostic laboratories, imaging centers, ambulatory care, and medical education. Revenue comes mainly from patient healthcare services, supplemented by laboratory services and management fees. IHH serves patients across Malaysia, Singapore, Turkey and Europe, India, Greater China, and other markets, with Turkey and Europe and Singapore among its largest revenue contributors. The company is listed on Bursa Malaysia and is majority-owned by Khazanah Nasional, Malaysia's sovereign wealth fund.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | 2.18 | |||||
Interest Coverage | 4.03 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.63 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.6 | |||||
3-Year EBITDA Growth Rate | 15.6 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | -1.1 | |||||
3-Year Book Growth Rate | 4.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.81 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.02 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 12.22 | |||||
9-Day RSI | 20.41 | |||||
14-Day RSI | 26.33 | |||||
3-1 Month Momentum % | -3.28 | |||||
6-1 Month Momentum % | -13.68 | |||||
12-1 Month Momentum % | 19.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.58 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 41.97 | |||||
Days Sales Outstanding | 46.68 | |||||
Days Payable | 212.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.41 | |||||
Dividend Payout Ratio | 0.46 | |||||
3-Year Dividend Growth Rate | 20.5 | |||||
Forward Dividend Yield % | 1.46 | |||||
5-Year Yield-on-Cost % | 4.51 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -1.12 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.15 | |||||
Operating Margin % | 15.45 | |||||
Net Margin % | 8.39 | |||||
EBITDA Margin % | 26.08 | |||||
FCF Margin % | 7.67 | |||||
OCF Margin % | 19.01 | |||||
ROE % | 7.37 | |||||
ROA % | 3.9 | |||||
ROIC % | 5.25 | |||||
3-Year ROIIC % | 7.09 | |||||
ROC (Joel Greenblatt) % | 19.76 | |||||
ROCE % | 10.48 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.52 | |||||
Forward PE Ratio | 25.11 | |||||
PE Ratio without NRI | 29.93 | |||||
Shiller PE Ratio | 41.04 | |||||
Price-to-Owner-Earnings | 29.31 | |||||
PEG Ratio | 1.55 | |||||
PS Ratio | 2.23 | |||||
PB Ratio | 1.92 | |||||
Price-to-Tangible-Book | 5.36 | |||||
Price-to-Free-Cash-Flow | 25.61 | |||||
Price-to-Operating-Cash-Flow | 10.88 | |||||
EV-to-EBIT | 17.17 | |||||
EV-to-Forward-EBIT | 16.3 | |||||
EV-to-EBITDA | 12.23 | |||||
EV-to-Forward-EBITDA | 11.37 | |||||
EV-to-Revenue | 3.19 | |||||
EV-to-Forward-Revenue | 2.55 | |||||
EV-to-FCF | 36.31 | |||||
Price-to-GF-Value | 0.87 | |||||
Price-to-Projected-FCF | 1.15 | |||||
Price-to-DCF (Earnings Based) | 2.07 | |||||
Price-to-DCF (FCF Based) | 2.48 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.84 | |||||
Price-to-Graham-Number | 2.68 | |||||
Earnings Yield (Greenblatt) % | 5.83 | |||||
FCF Yield % | 3.43 | |||||
Forward Rate of Return (Yacktman) % | 13.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IHH Healthcare Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil S$) | 8,413.064 | ||
| EPS (TTM) (S$) | 0.08 | ||
| Beta | 0.3049 | ||
| 3-Year Sharpe Ratio | 0.72 | ||
| 3-Year Sortino Ratio | 1.72 | ||
| Volatility % | 17.97 | ||
| 14-Day RSI | 26.33 | ||
| 14-Day ATR (S$) | 0.080891 | ||
| 20-Day SMA (S$) | 2.634 | ||
| 12-1 Month Momentum % | 19.91 | ||
| 52-Week Range (S$) | 2.2 - 3.07 | ||
| Shares Outstanding (Mil) | 8,836.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IHH Healthcare Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IHH Healthcare Bhd Stock Events
| Event | Date | Price (S$) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-03-02 | In 162 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 158 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-27 | In 67 days | ||
| Third quarter earnings results for 2026 | 2026-11-26 | In 66 days | ||
| MYR 0.055000 Cash Dividend | 2026-09-29 | In 8 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-27 | 2.65 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-27 | 2.65 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-26 | 2.91 (+1.04%) | ||
| First quarter earnings results for 2026 | 2026-05-26 | 2.91 (+1.04%) | ||
| General meeting for 2025 | 2026-05-25 14:00 | 2.88 (-0.69%) |
Show
Entries
IHH Healthcare Bhd Frequently Asked Questions
What is IHH Healthcare Bhd(SGX:Q0F)'s stock price today?
The current price of SGX:Q0F is S$2.36. The 52 week high of SGX:Q0F is S$3.07 and 52 week low is S$2.20.
When is next earnings date of IHH Healthcare Bhd(SGX:Q0F)?
The next earnings date of IHH Healthcare Bhd(SGX:Q0F) is 2026-11-26 Est..
Does IHH Healthcare Bhd(SGX:Q0F) pay dividends? If so, how much?
The Dividend Yield %  of IHH Healthcare Bhd(SGX:Q0F) is 1.41% (As of Today), Highest Dividend Payout Ratio of IHH Healthcare Bhd(SGX:Q0F) was 2.35. The lowest was 0.25. And the median was 0.5. The  Forward Dividend Yield % of IHH Healthcare Bhd(SGX:Q0F) is 1.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers